BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17426080)

  • 1. Anticoagulants in heart disease: current status and perspectives.
    De Caterina R; Husted S; Wallentin L; Agnelli G; Bachmann F; Baigent C; Jespersen J; Kristensen SD; Montalescot G; Siegbahn A; Verheugt FW; Weitz J
    Eur Heart J; 2007 Apr; 28(7):880-913. PubMed ID: 17426080
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulation assays and anticoagulant monitoring.
    Funk DM
    Hematology Am Soc Hematol Educ Program; 2012; 2012():460-5. PubMed ID: 23233620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor Xa and thrombin as targets for new oral anticoagulants.
    Weitz JI
    Thromb Res; 2011 Jan; 127 Suppl 2():S5-S12. PubMed ID: 21193114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.
    Beyer-Westendorf J; Ageno W
    Thromb Haemost; 2015 Feb; 113(2):231-46. PubMed ID: 25319150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation beyond direct thrombin and factor Xa inhibitors: indications for targeting the intrinsic pathway?
    van Montfoort ML; Meijers JC
    Thromb Haemost; 2013 Aug; 110(2):223-32. PubMed ID: 23739841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cellular effects of old and new oral anticoagulants: consequences to the genesis and progression of atherosclerosis.
    Schurgers LJ; Spronk HM
    Thromb Haemost; 2014 Nov; 112(5):909-17. PubMed ID: 25298033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Principles of the treatment of hypercoagulabilities with a rational anticoagulant therapy].
    Raby C
    Presse Med (1893); 1969 Jan; 77(1):17-9. PubMed ID: 5785756
    [No Abstract]   [Full Text] [Related]  

  • 8. Disadvantages of VKA and requirements for novel anticoagulants.
    Shameem R; Ansell J
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):103-14. PubMed ID: 23953899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of thrombus located in the left atrial appendage. Is it the right time for a Xa factor inhibitor?
    Baran J; Zaborska B; Sikora-Frąc M; Stec S; Kułakowski P
    Kardiol Pol; 2013; 71(11):1210. PubMed ID: 24297727
    [No Abstract]   [Full Text] [Related]  

  • 10. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Concepts in anticoagulant therapy - past, present, and future].
    Graf L
    Ther Umsch; 2012 Nov; 69(11):611-5. PubMed ID: 23117663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Atrial fibrillation: new anticoagulants are more effective and safer, but expensive].
    Steurer J
    Praxis (Bern 1994); 2014 Jun; 103(13):785-6. PubMed ID: 24938162
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxin-induced coagulopathy.
    Chai P; Babu K
    Emerg Med Clin North Am; 2014 Feb; 32(1):53-78. PubMed ID: 24275169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulants--the old and the new.
    Ansell J
    Dis Mon; 2005; 51(2-3):208-12. PubMed ID: 15900274
    [No Abstract]   [Full Text] [Related]  

  • 15. [New anticoagulants for secondary haemostasis--anti IIa inhibitors].
    Nowak G
    Hamostaseologie; 2009 Aug; 29(3):256-9. PubMed ID: 19644604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential antidotes for reversal of old and new oral anticoagulants.
    Suryanarayan D; Schulman S
    Thromb Res; 2014 May; 133 Suppl 2():S158-66. PubMed ID: 24862137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In practice: use of vitamin K antagonists].
    Heidinger K
    Pharm Unserer Zeit; 2004; 33(3):236-43. PubMed ID: 15208912
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bleeding during anti-vitamin K treatment. Incidence, risk factors and comparison with the new oral anticoagulants].
    Korin J
    Medicina (B Aires); 2012; 72(5):419-24. PubMed ID: 23089119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into direct anticoagulants.
    Saad E; Dally N
    Blood Coagul Fibrinolysis; 2015 Jul; 26(5):492-8. PubMed ID: 25828968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laboratory testing in the era of direct or non-vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors.
    Favaloro EJ; Lippi G
    Semin Thromb Hemost; 2015 Mar; 41(2):208-27. PubMed ID: 25703514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.